2023’s best medtech innovations
Category: Best Medical Technology
Nominee: CVRx’s Barostim
It was the first FDA-approved device ” that uses the power of the brain and nervous system to target cardiovascular disease,” CVRx President and CEO Nadim Yared said at the time.
Earlier this year, data from a clinical trial supported Barostim’s use as a safe, effective and durable treatment for patients with heart failure with reduced ejection fraction.